TG Therapeutics, Inc. (NASDAQ:TGTX) Receives $40.67 Average PT from Brokerages
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price […]
